Cargando…

Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries

The use of global standards, and the placement of barcodes and data matrix codes on vaccine labels and other levels of packaging are crucial elements for the traceability of finished vaccine products. Vaccine manufacturers are committed to improving health through their products, as vaccine producti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagliusi, Sonia, Madrid, Yvette, Bramanti, Yudha, Wilmansyah, Taufik, Yu, Huilin, Acebal, Analia, Krishnamurthy, Komarapuram R., Raju Pinnamaraju, Venkatapathi, Jadhav, Padmakar, Park, Rachel, Yang, Lingjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470265/
https://www.ncbi.nlm.nih.gov/pubmed/37663047
http://dx.doi.org/10.1016/j.jvacx.2023.100366
_version_ 1785099643669970944
author Pagliusi, Sonia
Madrid, Yvette
Bramanti, Yudha
Wilmansyah, Taufik
Yu, Huilin
Acebal, Analia
Krishnamurthy, Komarapuram R.
Raju Pinnamaraju, Venkatapathi
Jadhav, Padmakar
Park, Rachel
Yang, Lingjiang
author_facet Pagliusi, Sonia
Madrid, Yvette
Bramanti, Yudha
Wilmansyah, Taufik
Yu, Huilin
Acebal, Analia
Krishnamurthy, Komarapuram R.
Raju Pinnamaraju, Venkatapathi
Jadhav, Padmakar
Park, Rachel
Yang, Lingjiang
author_sort Pagliusi, Sonia
collection PubMed
description The use of global standards, and the placement of barcodes and data matrix codes on vaccine labels and other levels of packaging are crucial elements for the traceability of finished vaccine products. Vaccine manufacturers are committed to improving health through their products, as vaccine production offers opportunities that can be leveraged to benefit immunization systems. In 2019 the Developing Countries Vaccine Manufacturers Network (DCVMN) created the Supply Chain Initiative aimed at prioritize and explore traceability opportunities; concomitantly procurement agencies announced traceability requirements for vaccine global supply. Vaccine traceability brings benefits including supply chain reliability and safety through enhanced product movement visibility, and a reduction of falsified and expired vaccines circulating in the supply chain. DCVMN has coordinated the development and implementation of global traceability standards, at both primary and secondary vaccine packaging levels, to encourage and enable sharing these experiences. Six pilot studies in four different countries showed successful implementation, and constituted part of larger vaccine traceability work within the respective organizations. The main findings from these pilot studies indicated that stepwise approaches to the adoption of traceability standards allowed vaccine manufacturers to learn by doing, initially with lower risk, and to spread their investments over time. Because the value of traceability is in its scale of adoption and the use of the data, it remains important for all stakeholders to engage in and prioritize the journey of vaccine traceability, but also to suitably manage the financial risks. The DCVMN Supply Chain Initiative has demonstrated that its members are committed to driving supply system changes that benefit immunization, while recognizing that supply chain traceability is part of a larger healthcare ecosystem and should be adopted by countries and immunization programmes as well.
format Online
Article
Text
id pubmed-10470265
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104702652023-09-01 Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries Pagliusi, Sonia Madrid, Yvette Bramanti, Yudha Wilmansyah, Taufik Yu, Huilin Acebal, Analia Krishnamurthy, Komarapuram R. Raju Pinnamaraju, Venkatapathi Jadhav, Padmakar Park, Rachel Yang, Lingjiang Vaccine X Regular paper The use of global standards, and the placement of barcodes and data matrix codes on vaccine labels and other levels of packaging are crucial elements for the traceability of finished vaccine products. Vaccine manufacturers are committed to improving health through their products, as vaccine production offers opportunities that can be leveraged to benefit immunization systems. In 2019 the Developing Countries Vaccine Manufacturers Network (DCVMN) created the Supply Chain Initiative aimed at prioritize and explore traceability opportunities; concomitantly procurement agencies announced traceability requirements for vaccine global supply. Vaccine traceability brings benefits including supply chain reliability and safety through enhanced product movement visibility, and a reduction of falsified and expired vaccines circulating in the supply chain. DCVMN has coordinated the development and implementation of global traceability standards, at both primary and secondary vaccine packaging levels, to encourage and enable sharing these experiences. Six pilot studies in four different countries showed successful implementation, and constituted part of larger vaccine traceability work within the respective organizations. The main findings from these pilot studies indicated that stepwise approaches to the adoption of traceability standards allowed vaccine manufacturers to learn by doing, initially with lower risk, and to spread their investments over time. Because the value of traceability is in its scale of adoption and the use of the data, it remains important for all stakeholders to engage in and prioritize the journey of vaccine traceability, but also to suitably manage the financial risks. The DCVMN Supply Chain Initiative has demonstrated that its members are committed to driving supply system changes that benefit immunization, while recognizing that supply chain traceability is part of a larger healthcare ecosystem and should be adopted by countries and immunization programmes as well. Elsevier 2023-08-04 /pmc/articles/PMC10470265/ /pubmed/37663047 http://dx.doi.org/10.1016/j.jvacx.2023.100366 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular paper
Pagliusi, Sonia
Madrid, Yvette
Bramanti, Yudha
Wilmansyah, Taufik
Yu, Huilin
Acebal, Analia
Krishnamurthy, Komarapuram R.
Raju Pinnamaraju, Venkatapathi
Jadhav, Padmakar
Park, Rachel
Yang, Lingjiang
Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title_full Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title_fullStr Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title_full_unstemmed Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title_short Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
title_sort vaccine traceability: key learnings from the supply chain initiative by manufacturers from emerging countries
topic Regular paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470265/
https://www.ncbi.nlm.nih.gov/pubmed/37663047
http://dx.doi.org/10.1016/j.jvacx.2023.100366
work_keys_str_mv AT pagliusisonia vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT madridyvette vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT bramantiyudha vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT wilmansyahtaufik vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT yuhuilin vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT acebalanalia vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT krishnamurthykomarapuramr vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT rajupinnamarajuvenkatapathi vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT jadhavpadmakar vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT parkrachel vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries
AT yanglingjiang vaccinetraceabilitykeylearningsfromthesupplychaininitiativebymanufacturersfromemergingcountries